Trademark: 77670202
Word
AREPANRIX
Status
Dead
Status Code
710
Status Date
Friday, October 27, 2017
Serial Number
77670202
Registration Number
3933238
Registration Date
Tuesday, March 22, 2011
Mark Type
4000
Filing Date
Friday, February 13, 2009
Published for Opposition
Tuesday, June 16, 2009
Cancellation Date
Friday, October 27, 2017

Trademark Owner History
GlaxoSmithKline Biologicals S.A. - Original Registrant

Classifications
5 Vaccines for the treatment and prevention of influenza

Trademark Events
Oct 27, 2017
Cancelled Sec. 8 (6-Yr)
Mar 22, 2016
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 8, 2015
Teas Change Of Correspondence Received
Jun 7, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 7, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 15, 2013
Teas Change Of Correspondence Received
Feb 20, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 20, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 22, 2011
Registered-Principal Register
Feb 16, 2011
1(B) Basis Deleted; Proceed To Registration
Feb 15, 2011
Notice Of Allowance Cancelled
Feb 15, 2011
Teas Post Publication Amendment Received
Sep 16, 2010
Notice Of Approval Of Extension Request E-Mailed
Sep 15, 2010
Extension 2 Granted
Sep 8, 2010
Extension 2 Filed
Sep 8, 2010
Teas Extension Received
May 13, 2010
Teas Change Of Correspondence Received
Mar 24, 2010
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2010
Extension 1 Granted
Feb 18, 2010
Extension 1 Filed
Mar 23, 2010
Case Assigned To Intent To Use Paralegal
Feb 18, 2010
Teas Extension Received
Oct 24, 2009
Teas Change Of Correspondence Received
Sep 8, 2009
Noa Mailed - Sou Required From Applicant
Jun 16, 2009
Published For Opposition
May 27, 2009
Notice Of Publication
May 11, 2009
Law Office Publication Review Completed
May 8, 2009
Assigned To Lie
May 8, 2009
Approved For Pub - Principal Register
May 5, 2009
Assigned To Examiner
Feb 18, 2009
New Application Office Supplied Data Entered In Tram
Feb 18, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24